Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621)
2021 performance report of the special audit committee of the board of directors
Dear directors
In accordance with the requirements of relevant national laws, regulations and regulatory rules, such as the standards for the governance of listed companies, the guidelines for self-discipline supervision of companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation, the Listing Rules of the science and Innovation Board of Shanghai Stock Exchange, as well as the provisions of the articles of association and the rules of procedure of the special committee of the board of directors, The audit committee of the board of directors of the company abided by its duties and earnestly fulfilled its obligations of audit supervision and professional services. The report of the Committee on the performance of its duties in 2021 is as follows:
1、 Basic information of the special audit committee of the board of directors
The members of the special audit committee of the board of directors of the company elected at the first meeting of the first board of directors of the company: Mr. Shu Zhemin, Mr. Hu Xuefeng and Mr. Zhao Lingyang. Among them, Mr. Shu Zhemin and Mr. Hu Xuefeng are independent directors of the company, and the chairman is Mr. Shu Zhemin with the qualification of certified public accountant and registered tax agent.
2、 Meetings of the special audit committee of the board of directors in 2021
During the reporting period, the special audit committee of the board of directors held three meetings through the combination of on-site voting and communication voting, as follows:
On March 25, 2021, the special audit committee held the fourth meeting of the first audit committee, deliberated and adopted the proposal on the company’s 2020 annual financial statement report, the proposal on the company’s 2020 annual profit distribution plan and other proposals, and agreed to submit them to the board of directors for deliberation.
On August 16, 2021, the special audit committee held the fifth meeting of the first audit committee, deliberated and adopted the proposal on the company’s 2021 semi annual report and its summary, the proposal on implementing the new leasing standards and changing relevant accounting policies and other proposals, and agreed to submit them to the board of directors for deliberation.
On October 25, 2021, the special audit committee held the sixth meeting of the first audit committee, deliberated and adopted the proposal on the company’s report for the third quarter of 2021, and agreed to submit the proposal to the board of directors for deliberation.
3、 Main work contents of the special audit committee of the board of directors in 2021
(I) propose to hire or replace the external audit institution and supervise the professional behavior of the external audit institution
As an external audit institution appointed by the board of directors of the company, Dahua certified public accountants has the relevant qualifications to engage in Securities and futures business, can provide professional services for the company and effectively play the functions of audit supervision and professional services.
On March 25, 2021, the fourth meeting of the first Audit Committee deliberated and approved the proposal on the company’s continued employment of Dahua Certified Public Accountants (special general partnership) as the company’s audit institution in 2021, and recommended that the board of directors continue to employ Dahua Certified Public Accountants (special general partnership) to provide professional audit services for the company. (II) check the company’s financial report and express opinions
In 2021, the special audit committee of the board of directors carefully reviewed the company’s financial information and disclosure, and believed that the preparation of the company’s financial statements was true, reliable and complete, there were no major accounting errors, adjustments, matters involving important accounting judgments and the issuance of non-standard and unprotected audit reports. The company’s internal auditors were diligent and responsible, Provide professional audit services for the company.
(III) guidance on the company’s internal audit
During the reporting period, the special audit committee of the board of directors supervised the legal compliance and financial management of various businesses of the company, and evaluated the integrity, rationality and effectiveness of the implementation of the internal audit system. We carefully reviewed the work plan formulated by the internal audit department of the company and urged it to complete corresponding tasks regularly according to the plan, We believe that the company’s internal audit system is sound and can complete the company’s internal audit work with high quality and efficiency, without major problems.
(IV) audit of internal control governance
The company has formulated a scientific, reasonable and effective internal control standard system in accordance with the company law of the people’s Republic of China and other laws, regulations, normative documents and the articles of association. During the reporting period, the company strictly followed laws and regulations, the company’s internal control management system was effectively implemented, and the general meeting of shareholders, the board of directors and the board of supervisors continued to operate in a standardized manner.
(V) comprehensively evaluate the annual audit work of external audit institutions
During the reporting period, we believe that Dahua Certified Public Accountants (special general partnership) can provide professional audit services for the company’s annual audit based on the principles of independence, objectivity and prudence, audit process planning, serious and diligent working attitude, objective and fair audit results, and better complete the audit business entrusted by the company.
4、 Overall evaluation
During the reporting period, the special audit committee of the board of directors was responsible to the board of directors in accordance with the requirements of relevant national laws, regulations and regulatory rules and the relevant provisions of the articles of association, earnestly performed corresponding responsibilities, treated all shareholders fairly and paid attention to the interests of other stakeholders. In 2022, the audit committee will continue to provide professional audit and supervision services for the company, abide by its duties, be diligent and responsible, and safeguard the common interests of the company and all shareholders.
It is hereby reported.
Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) special audit committee of the board of directors February 25, 2022 (this page is blank and is the signature page of the 2021 annual performance report of Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) special audit committee of the board of directors)
Member of the special audit committee of the board of directors (signature)
Hu Xuefeng, Shu Zhemin, Zhao Lingyang
Signed on: February 25, 2022
